Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypetension

A Randomized, Double-blind, Multicenter, Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypertension

A Randomized, Double-blind, Multicenter, Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypertension

Inclusion Criteria:

• Patients who are 19 years or older / 75 years or younger on screening
• Signed informed consent
• Patients with Essential Hypertension
• Other inclusion applied

Exclusion Criteria:

• Orthostatic hypertension with symptom
• Other exclusion applied